Cargando…
Implication of the hepatokine, fibrinogen-like protein 1 in liver diseases, metabolic disorders and cancer: The need to harness its full potential
Fibrinogen-like protein 1 (FGL1) is a novel hepatokine that forms part of the fibrinogen superfamily. It is predominantly expressed in the liver under normal physiological conditions. When the liver is injured by external factors, such as chemical drugs and radiation, FGL1 acts as a protective facto...
Autores principales: | Liu, Xi-Hua, Qi, Lian-Wen, Alolga, Raphael N., Liu, Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692158/ https://www.ncbi.nlm.nih.gov/pubmed/34975333 http://dx.doi.org/10.7150/ijbs.66834 |
Ejemplares similares
-
Implication of hepatokines in metabolic disorders and cardiovascular diseases
por: Jung, Tae Woo, et al.
Publicado: (2016) -
Hepatokines and metabolism: Deciphering communication from the liver
por: Jensen-Cody, Sharon O., et al.
Publicado: (2020) -
Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
por: Kim, Tae Hyun, et al.
Publicado: (2021) -
Role of Hepatokines in Non-alcoholic Fatty Liver Disease
por: Ke, Yini, et al.
Publicado: (2019) -
Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions
por: de Oliveira dos Santos, Ana Rita, et al.
Publicado: (2021)